Compare Kimco Realty Corporation (HC) Common Stock (KIM) vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kimco Realty Corporation (HC) Common Stock vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? Kimco Realty Corporation (HC) Common Stock trades at $22.17 (market cap $14.82B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.72 (market cap $58.74B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 4× Kimco Realty Corporation (HC) Common Stock's market cap, and Kimco Realty Corporation (HC) Common Stock pays the higher dividend (5.07%). Which is the better fit depends on your goals — on Pluang, investors hold Kimco Realty Corporation (HC) Common Stock for 1 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 1 Days on average.
| KIM | TAK | |
|---|---|---|
Market Cap | $14.82B | $58.74B |
Volume | 5,158,462 | 3,110,994 |
Sector | Real Estate | Health |
52-Week High | $26.38 | $19.05 |
52-Week Low | $19.78 | $13.23 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $22.98B | $86.65B |
Dividend Yield | 5.07% | 3.33% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kimco Realty Corporation (HC) Common Stock
Kimco Realty is a real estate investment trust that owns and operates open-air, grocery-anchored shopping centers and mixed-use properties in the United States.
Read more on KIM →About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →
